0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Antibody Market Insights and Forecast to 2027
Published Date: May 2021
|
Report Code: QYRE-Auto-0321
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
Global Antibody Market Insights and Forecast to 2027

Global Antibody Market Insights and Forecast to 2027

Code: QYRE-Auto-0321
Report
May 2021
154 Pages
QYResearch
Region: Global, China,
Description
Table of Content
Tables & Figures
Antibody market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Antibody market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type

IgM
IgG
IgA
Other

Segment by Application

Therapeutic
Research
Diagnostic

BY COMPANY

Roche
Johnson & Johnson
Merck
Novartis
AbbVie
Amgen
Pfizer
Bayer
Lilly
Bristol-Myers Squibb
GlaxoSmithKline
Biogen
AstraZeneca
Sanofi
Alexion Pharmaceuticals
Seattle Genetics

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
1 Study Coverage
1.1 Antibody Product Introduction
1.2 Market by Type
1.2.1 Global Antibody Market Size Growth Rate by Type
1.4.2 IgM
1.4.3 IgG
1.2.4 IgA
1.2.5 Other
1.3 Market by Application
1.3.1 Global Antibody Market Size Growth Rate by Application
1.3.2 Therapeutic
1.3.3 Research
1.3.4 Diagnostic
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Antibody Sales Estimates and Forecasts 2016-2027
2.2 Global Antibody Revenue Estimates and Forecasts 2016-2027
2.3 Global Antibody Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Antibody Regions by Sales
2.4.1 Global Top Antibody Regions by Sales (2016-2021)
2.4.2 Global Top Antibody Regions by Sales (2022-2027)
2.5 Global Top Antibody Regions by Revenue
2.5.1 Global Top Antibody Regions by Revenue (2016-2021)
2.5.2 Global Top Antibody Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Antibody Sales by Manufacturers
3.1.1 Global Top Antibody Manufacturers by Sales (2016-2021)
3.1.2 Global Top Antibody Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Antibody Sales in 2020
3.2 Global Antibody Revenue by Manufacturers
3.2.1 Global Top Antibody Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Antibody Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Antibody Revenue in 2020
3.3 Global Antibody Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Antibody Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Antibody Sales by Type
4.1.1 Global Antibody Historical Sales by Type (2016-2021)
4.1.2 Global Antibody Forecasted Sales by Type (2022-2027)
4.1.3 Global Antibody Sales Market Share by Type (2016-2027)
4.2 Global Antibody Revenue by Type
4.2.1 Global Antibody Historical Revenue by Type (2016-2021)
4.2.2 Global Antibody Forecasted Revenue by Type (2022-2027)
4.2.3 Global Antibody Revenue Market Share by Type (2016-2027)
4.3 Global Antibody Price by Type
4.3.1 Global Antibody Price by Type (2016-2021)
4.3.2 Global Antibody Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Antibody Sales by Application
5.1.1 Global Antibody Historical Sales by Application (2016-2021)
5.1.2 Global Antibody Forecasted Sales by Application (2022-2027)
5.1.3 Global Antibody Sales Market Share by Application (2016-2027)
5.2 Global Antibody Revenue by Application
5.2.1 Global Antibody Historical Revenue by Application (2016-2021)
5.2.2 Global Antibody Forecasted Revenue by Application (2022-2027)
5.2.3 Global Antibody Revenue Market Share by Application (2016-2027)
5.3 Global Antibody Price by Application
5.3.1 Global Antibody Price by Application (2016-2021)
5.3.2 Global Antibody Price Forecast by Application (2022-2027)
6 North America
6.1 North America Antibody Market Size by Type
6.1.1 North America Antibody Sales by Type (2016-2027)
6.1.2 North America Antibody Revenue by Type (2016-2027)
6.2 North America Antibody Market Size by Application
6.2.1 North America Antibody Sales by Application (2016-2027)
6.2.2 North America Antibody Revenue by Application (2016-2027)
6.3 North America Antibody Market Size by Country
6.3.1 North America Antibody Sales by Country (2016-2027)
6.3.2 North America Antibody Revenue by Country (2016-2027)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Antibody Market Size by Type
7.1.1 Europe Antibody Sales by Type (2017-2027)
7.1.2 Europe Antibody Revenue by Type (2017-2027)
7.2 Europe Antibody Market Size by Application
7.2.1 Europe Antibody Sales by Application (2017-2027)
7.2.2 Europe Antibody Revenue by Application (2017-2027)
7.3 Europe Antibody Market Size by Country
7.3.1 Europe Antibody Sales by Country (2017-2027)
7.3.2 Europe Antibody Revenue by Country (2017-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Antibody Market Size by Type
8.1.1 Asia Pacific Antibody Sales by Type (2018-2027)
8.1.2 Asia Pacific Antibody Revenue by Type (2018-2027)
8.2 Asia Pacific Antibody Market Size by Application
8.2.1 Asia Pacific Antibody Sales by Application (2018-2027)
8.2.2 Asia Pacific Antibody Revenue by Application (2018-2027)
8.3 Asia Pacific Antibody Market Size by Region
8.3.1 Asia Pacific Antibody Sales by Region (2018-2027)
8.3.2 Asia Pacific Antibody Revenue by Region (2018-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Antibody Market Size by Type
9.1.1 Latin America Antibody Sales by Type (2019-2027)
9.1.2 Latin America Antibody Revenue by Type (2019-2027)
9.2 Latin America Antibody Market Size by Application
9.2.1 Latin America Antibody Sales by Application (2019-2027)
9.2.2 Latin America Antibody Revenue by Application (2019-2027)
9.3 Latin America Antibody Market Size by Country
9.3.1 Latin America Antibody Sales by Country (2019-2027)
9.3.2 Latin America Antibody Revenue by Country (2019-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
6 Middle East and Africa
6.1 Middle East and Africa Antibody Market Size by Type
6.1.1 Middle East and Africa Antibody Sales by Type (2016-2027)
6.1.2 Middle East and Africa Antibody Revenue by Type (2016-2027)
6.2 Middle East and Africa Antibody Market Size by Application
6.2.1 Middle East and Africa Antibody Sales by Application (2016-2027)
6.2.2 Middle East and Africa Antibody Revenue by Application (2016-2027)
6.3 Middle East and Africa Antibody Market Size by Country
6.3.1 Middle East and Africa Antibody Sales by Country (2016-2027)
6.3.2 Middle East and Africa Antibody Revenue by Country (2016-2027)
6.3.3 Turkey
6.3.4 Saudi Arabia
6.3.5 U.A.E
11 Company Profiles
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Overview
11.1.3 Roche Antibody Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Roche Antibody Product Description
11.1.5 Roche Related Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Corporation Information
11.2.2 Johnson & Johnson Overview
11.2.3 Johnson & Johnson Antibody Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Johnson & Johnson Antibody Product Description
11.2.5 Johnson & Johnson Related Developments
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Overview
11.3.3 Merck Antibody Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Merck Antibody Product Description
11.3.5 Merck Related Developments
11.4 Novartis
11.4.1 Novartis Corporation Information
11.4.2 Novartis Overview
11.4.3 Novartis Antibody Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Novartis Antibody Product Description
11.4.5 Novartis Related Developments
11.5 AbbVie
11.5.1 AbbVie Corporation Information
11.5.2 AbbVie Overview
11.5.3 AbbVie Antibody Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 AbbVie Antibody Product Description
11.5.5 AbbVie Related Developments
11.6 Amgen
11.6.1 Amgen Corporation Information
11.6.2 Amgen Overview
11.6.3 Amgen Antibody Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Amgen Antibody Product Description
11.6.5 Amgen Related Developments
11.7 Pfizer
11.7.1 Pfizer Corporation Information
11.7.2 Pfizer Overview
11.7.3 Pfizer Antibody Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Pfizer Antibody Product Description
11.7.5 Pfizer Related Developments
11.8 Bayer
11.8.1 Bayer Corporation Information
11.8.2 Bayer Overview
11.8.3 Bayer Antibody Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Bayer Antibody Product Description
11.8.5 Bayer Related Developments
11.9 Lilly
11.9.1 Lilly Corporation Information
11.9.2 Lilly Overview
11.9.3 Lilly Antibody Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Lilly Antibody Product Description
11.9.5 Lilly Related Developments
11.10 Bristol-Myers Squibb
11.10.1 Bristol-Myers Squibb Corporation Information
11.10.2 Bristol-Myers Squibb Overview
11.10.3 Bristol-Myers Squibb Antibody Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 Bristol-Myers Squibb Antibody Product Description
11.10.5 Bristol-Myers Squibb Related Developments
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Overview
11.1.3 Roche Antibody Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Roche Antibody Product Description
11.1.5 Roche Related Developments
11.12 Biogen
11.12.1 Biogen Corporation Information
11.12.2 Biogen Overview
11.12.3 Biogen Antibody Sales, Price, Revenue and Gross Margin (2016-2021)
11.12.4 Biogen Product Description
11.12.5 Biogen Related Developments
11.13 AstraZeneca
11.13.1 AstraZeneca Corporation Information
11.13.2 AstraZeneca Overview
11.13.3 AstraZeneca Antibody Sales, Price, Revenue and Gross Margin (2016-2021)
11.13.4 AstraZeneca Product Description
11.13.5 AstraZeneca Related Developments
11.14 Sanofi
11.14.1 Sanofi Corporation Information
11.14.2 Sanofi Overview
11.14.3 Sanofi Antibody Sales, Price, Revenue and Gross Margin (2016-2021)
11.14.4 Sanofi Product Description
11.14.5 Sanofi Related Developments
11.15 Alexion Pharmaceuticals
11.15.1 Alexion Pharmaceuticals Corporation Information
11.15.2 Alexion Pharmaceuticals Overview
11.15.3 Alexion Pharmaceuticals Antibody Sales, Price, Revenue and Gross Margin (2016-2021)
11.15.4 Alexion Pharmaceuticals Product Description
11.15.5 Alexion Pharmaceuticals Related Developments
11.16 Seattle Genetics
11.16.1 Seattle Genetics Corporation Information
11.16.2 Seattle Genetics Overview
11.16.3 Seattle Genetics Antibody Sales, Price, Revenue and Gross Margin (2016-2021)
11.16.4 Seattle Genetics Product Description
11.16.5 Seattle Genetics Related Developments
12 Value Chain and Sales Channels Analysis
12.1 Antibody Value Chain Analysis
12.2 Antibody Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Antibody Production Mode & Process
12.4 Antibody Sales and Marketing
12.4.1 Antibody Sales Channels
12.4.2 Antibody Distributors
12.5 Antibody Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Antibody Industry Trends
13.2 Antibody Market Drivers
13.3 Antibody Market Challenges
13.4 Antibody Market Restraints
14 Key Findings in The Global Antibody Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Antibody Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
    Table 2. Major Manufacturers of IgM
    Table 3. Major Manufacturers of IgG
    Table 4. Major Manufacturers of IgA
    Table 5. Major Manufacturers of Other
    Table 6. Global Antibody Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
    Table 7. Global Antibody Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
    Table 8. Global Antibody Sales by Region (2016-2021) & (MT)
    Table 9. Global Antibody Sales Market Share by Region (2016-2021)
    Table 10. Global Antibody Sales by Region (2016-2021) & (MT)
    Table 11. Global Antibody Sales Market Share by Region (2022-2027)
    Table 12. Global Antibody Revenue by Region (2016-2021) & (US$ Million)
    Table 13. Global Antibody Revenue Market Share by Region (2016-2021)
    Table 14. Global Antibody Revenue by Region (2022-2027) & (US$ Million)
    Table 15. Global Antibody Revenue Market Share by Region (2022-2027)
    Table 16. Global Antibody Sales by Manufacturers (2016-2021) & (MT)
    Table 17. Global Antibody Sales Share by Manufacturers (2016-2021)
    Table 18. Global Antibody Revenue by Manufacturers (2016-2021) & (US$ Million)
    Table 19. Global Antibody Revenue Share by Manufacturers (2016-2021)
    Table 20. Antibody Price by Manufacturers 2016-2021 (USD/MT)
    Table 21. Global Antibody Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody as of 2020)
    Table 23. Antibody Manufacturing Base Distribution and Headquarters
    Table 24. Manufacturers Antibody Product Offered
    Table 25. Date of Manufacturers Enter into Antibody Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Antibody Sales by Type (2016-2021) & (MT)
    Table 28. Global Antibody Sales by Type (2022-2027) & (MT)
    Table 29. Global Antibody Sales Share by Type (2016-2021)
    Table 30. Global Antibody Sales Share by Type (2022-2027)
    Table 31. Global Antibody Revenue by Type (2016-2021) & (US$ Million)
    Table 32. Global Antibody Revenue by Type (2022-2027) & (US$ Million)
    Table 33. Global Antibody Revenue Share by Type (2016-2021)
    Table 34. Global Antibody Revenue Share by Type (2022-2027)
    Table 35. Antibody Price by Type (2016-2021) & (USD/MT)
    Table 36. Global Antibody Price Forecast by Type (2022-2027) & (USD/MT)
    Table 37. Global Antibody Sales by Application (2016-2021) & (MT)
    Table 38. Global Antibody Sales by Application (2022-2027) & (MT)
    Table 39. Global Antibody Sales Share by Application (2016-2021)
    Table 40. Global Antibody Sales Share by Application (2022-2027)
    Table 41. Global Antibody Revenue by Application (2016-2021) & (US$ Million)
    Table 42. Global Antibody Revenue by Application (2022-2027) & (US$ Million)
    Table 43. Global Antibody Revenue Share by Application (2016-2021)
    Table 44. Global Antibody Revenue Share by Application (2022-2027)
    Table 45. Antibody Price by Application (2016-2021) & (USD/MT)
    Table 46. Global Antibody Price Forecast by Application (2022-2027) & (USD/MT)
    Table 47. North America Antibody Sales by Type (2016-2021) & (MT)
    Table 48. North America Antibody Sales by Type (2022-2027) & (MT)
    Table 49. North America Antibody Revenue by Type (2016-2021) & (US$ Million)
    Table 50. North America Antibody Revenue by Type (2022-2027) & (US$ Million)
    Table 51. North America Antibody Sales by Application (2016-2021) & (MT)
    Table 52. North America Antibody Sales by Application (2022-2027) & (MT)
    Table 53. North America Antibody Revenue by Application (2016-2021) & (US$ Million)
    Table 54. North America Antibody Revenue by Application (2022-2027) & (US$ Million)
    Table 55. North America Antibody Sales by Country (2016-2021) & (MT)
    Table 56. North America Antibody Sales by Country (2022-2027) & (MT)
    Table 57. North America Antibody Revenue by Country (2016-2021) & (US$ Million)
    Table 58. North America Antibody Revenue by Country (2022-2027) & (US$ Million)
    Table 59. Europe Antibody Sales by Type (2016-2021) & (MT)
    Table 60. Europe Antibody Sales by Type (2022-2027) & (MT)
    Table 61. Europe Antibody Revenue by Type (2016-2021) & (US$ Million)
    Table 62. Europe Antibody Revenue by Type (2022-2027) & (US$ Million)
    Table 63. Europe Antibody Sales by Application (2016-2021) & (MT)
    Table 64. Europe Antibody Sales by Application (2022-2027) & (MT)
    Table 65. Europe Antibody Revenue by Application (2016-2021) & (US$ Million)
    Table 66. Europe Antibody Revenue by Application (2022-2027) & (US$ Million)
    Table 67. Europe Antibody Sales by Country (2016-2021) & (MT)
    Table 68. Europe Antibody Sales by Country (2022-2027) & (MT)
    Table 69. Europe Antibody Revenue by Country (2016-2021) & (US$ Million)
    Table 70. Europe Antibody Revenue by Country (2022-2027) & (US$ Million)
    Table 71. Asia Pacific Antibody Sales by Type (2016-2021) & (MT)
    Table 72. Asia Pacific Antibody Sales by Type (2022-2027) & (MT)
    Table 73. Asia Pacific Antibody Revenue by Type (2016-2021) & (US$ Million)
    Table 74. Asia Pacific Antibody Revenue by Type (2022-2027) & (US$ Million)
    Table 75. Asia Pacific Antibody Sales by Application (2016-2021) & (MT)
    Table 76. Asia Pacific Antibody Sales by Application (2022-2027) & (MT)
    Table 77. Asia Pacific Antibody Revenue by Application (2016-2021) & (US$ Million)
    Table 78. Asia Pacific Antibody Revenue by Application (2022-2027) & (US$ Million)
    Table 79. Asia Pacific Antibody Sales by Region (2016-2021) & (MT)
    Table 80. Asia Pacific Antibody Sales by Region (2022-2027) & (MT)
    Table 81. Asia Pacific Antibody Revenue by Region (2016-2021) & (US$ Million)
    Table 82. Asia Pacific Antibody Revenue by Region (2022-2027) & (US$ Million)
    Table 83. Latin America Antibody Sales by Type (2016-2021) & (MT)
    Table 84. Latin America Antibody Sales by Type (2022-2027) & (MT)
    Table 85. Latin America Antibody Revenue by Type (2016-2021) & (US$ Million)
    Table 86. Latin America Antibody Revenue by Type (2022-2027) & (US$ Million)
    Table 87. Latin America Antibody Sales by Application (2016-2021) & (MT)
    Table 88. Latin America Antibody Sales by Application (2022-2027) & (MT)
    Table 89. Latin America Antibody Revenue by Application (2016-2021) & (US$ Million)
    Table 90. Latin America Antibody Revenue by Application (2022-2027) & (US$ Million)
    Table 91. Latin America Antibody Sales by Country (2016-2021) & (MT)
    Table 92. Latin America Antibody Sales by Country (2022-2027) & (MT)
    Table 93. Latin America Antibody Revenue by Country (2016-2021) & (US$ Million)
    Table 94. Latin America Antibody Revenue by Country (2022-2027) & (US$ Million)
    Table 95. Middle East and Africa Antibody Sales by Type (2016-2021) & (MT)
    Table 96. Middle East and Africa Antibody Sales by Type (2022-2027) & (MT)
    Table 97. Middle East and Africa Antibody Revenue by Type (2016-2021) & (US$ Million)
    Table 98. Middle East and Africa Antibody Revenue by Type (2022-2027) & (US$ Million)
    Table 99. Middle East and Africa Antibody Sales by Application (2016-2021) & (MT)
    Table 100. Middle East and Africa Antibody Sales by Application (2022-2027) & (MT)
    Table 101. Middle East and Africa Antibody Revenue by Application (2016-2021) & (US$ Million)
    Table 102. Middle East and Africa Antibody Revenue by Application (2022-2027) & (US$ Million)
    Table 103. Middle East and Africa Antibody Sales by Country (2016-2021) & (MT)
    Table 104. Middle East and Africa Antibody Sales by Country (2022-2027) & (MT)
    Table 105. Middle East and Africa Antibody Revenue by Country (2016-2021) & (US$ Million)
    Table 106. Middle East and Africa Antibody Revenue by Country (2022-2027) & (US$ Million)
    Table 107. Roche Corporation Information
    Table 108. Roche Description and Major Businesses
    Table 109. Roche Antibody Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 110. Roche Antibody Product
    Table 111. Roche Recent Developments
    Table 112. Johnson & Johnson Corporation Information
    Table 113. Johnson & Johnson Description and Major Businesses
    Table 114. Johnson & Johnson Antibody Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 115. Johnson & Johnson Antibody Product
    Table 116. Johnson & Johnson Recent Developments
    Table 117. Merck Corporation Information
    Table 118. Merck Description and Major Businesses
    Table 119. Merck Antibody Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 120. Merck Antibody Product
    Table 121. Merck Recent Developments
    Table 122. Novartis Corporation Information
    Table 123. Novartis Description and Major Businesses
    Table 124. Novartis Antibody Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 125. Novartis Antibody Product
    Table 126. Novartis Recent Developments
    Table 127. AbbVie Corporation Information
    Table 128. AbbVie Description and Major Businesses
    Table 129. AbbVie Antibody Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 130. AbbVie Antibody Product
    Table 131. AbbVie Recent Developments
    Table 132. Amgen Corporation Information
    Table 133. Amgen Description and Major Businesses
    Table 134. Amgen Antibody Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 135. Amgen Antibody Product
    Table 136. Amgen Recent Developments
    Table 137. Pfizer Corporation Information
    Table 138. Pfizer Description and Major Businesses
    Table 139. Pfizer Antibody Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 140. Pfizer Antibody Product
    Table 141. Pfizer Recent Developments
    Table 142. Bayer Corporation Information
    Table 143. Bayer Description and Major Businesses
    Table 144. Bayer Antibody Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 145. Bayer Antibody Product
    Table 146. Bayer Recent Developments
    Table 147. Lilly Corporation Information
    Table 148. Lilly Description and Major Businesses
    Table 149. Lilly Antibody Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 150. Lilly Antibody Product
    Table 151. Lilly Recent Developments
    Table 152. Bristol-Myers Squibb Corporation Information
    Table 153. Bristol-Myers Squibb Description and Major Businesses
    Table 154. Bristol-Myers Squibb Antibody Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 155. Bristol-Myers Squibb Antibody Product
    Table 156. Bristol-Myers Squibb Recent Developments
    Table 157. GlaxoSmithKline Corporation Information
    Table 158. GlaxoSmithKline Description and Major Businesses
    Table 159. GlaxoSmithKline Antibody Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 160. GlaxoSmithKline Antibody Product
    Table 161. GlaxoSmithKline Recent Developments
    Table 162. Biogen Corporation Information
    Table 163. Biogen Description and Major Businesses
    Table 164. Biogen Antibody Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 165. Biogen Antibody Product
    Table 166. Biogen Recent Developments
    Table 167. AstraZeneca Corporation Information
    Table 168. AstraZeneca Description and Major Businesses
    Table 169. AstraZeneca Antibody Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 170. AstraZeneca Antibody Product
    Table 171. AstraZeneca Recent Developments
    Table 172. Sanofi Corporation Information
    Table 173. Sanofi Description and Major Businesses
    Table 174. Sanofi Antibody Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 175. Sanofi Antibody Product
    Table 176. Sanofi Recent Developments
    Table 177. Alexion Pharmaceuticals Corporation Information
    Table 178. Alexion Pharmaceuticals Description and Major Businesses
    Table 179. Alexion Pharmaceuticals Antibody Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 180. Alexion Pharmaceuticals Antibody Product
    Table 181. Alexion Pharmaceuticals Recent Developments
    Table 182. Seattle Genetics Corporation Information
    Table 183. Seattle Genetics Description and Major Businesses
    Table 184. Seattle Genetics Antibody Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 185. Seattle Genetics Antibody Product
    Table 186. Seattle Genetics Recent Developments
    Table 187. Key Raw Materials Lists
    Table 188. Raw Materials Key Suppliers Lists
    Table 189. Antibody Distributors List
    Table 190. Antibody Customers List
    Table 191. Antibody Market Trends
    Table 192. Antibody Market Drivers
    Table 193. Antibody Market Challenges
    Table 194. Antibody Market Restraints
    Table 195. Research Programs/Design for This Report
    Table 196. Key Data Information from Secondary Sources
    Table 197. Key Data Information from Primary Sources
List of Figures
    Figure 1. Antibody Product Picture
    Figure 2. Global Antibody Market Share by Type in 2020 & 2027
    Figure 3. IgM Product Picture
    Figure 4. IgG Product Picture
    Figure 5. IgA Product Picture
    Figure 6. Other Product Picture
    Figure 7. Global Antibody Sales Market Share by Application in 2020 & 2027
    Figure 8. Therapeutic
    Figure 9. Research
    Figure 10. Diagnostic
    Figure 11. Antibody Report Years Considered
    Figure 12. Global Antibody Sales 2016-2027 (MT)
    Figure 13. Global Antibody Revenue, (US$ Million), 2016 VS 2021 VS 2027
    Figure 14. Global Antibody Revenue 2016-2027 (US$ Million)
    Figure 15. Global Antibody Revenue Market Share by Region in Percentage: 2020 Versus 2027
    Figure 16. Global Antibody Sales Market Share by Region (2016-2021)
    Figure 17. Global Antibody Sales Market Share by Region (2022-2027)
    Figure 18. North America Antibody Sales YoY (2016-2027) & (MT)
    Figure 19. North America Antibody Revenue YoY (2016-2027) & (US$ Million)
    Figure 20. Europe Antibody Sales YoY (2016-2027) & (MT)
    Figure 21. Europe Antibody Revenue YoY (2016-2027) & (US$ Million)
    Figure 22. Asia-Pacific Antibody Sales YoY (2016-2027) & (MT)
    Figure 23. Asia-Pacific Antibody Revenue YoY (2016-2027) & (US$ Million)
    Figure 24. Latin America Antibody Sales YoY (2016-2027) & (MT)
    Figure 25. Latin America Antibody Revenue YoY (2016-2027) & (US$ Million)
    Figure 26. Middle East & Africa Antibody Sales YoY (2016-2027) & (MT)
    Figure 27. Middle East & Africa Antibody Revenue YoY (2016-2027) & (US$ Million)
    Figure 28. The Top 10 and Top 5 Players Market Share by Antibody Sales in 2020
    Figure 29. The Top 10 and Top 5 Players Market Share by Antibody Revenue in 2020
    Figure 30. Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
    Figure 31. Global Antibody Sales Market Share by Type (2016-2027)
    Figure 32. Global Antibody Revenue Market Share by Type (2016-2027)
    Figure 33. Global Antibody Sales Market Share by Application (2016-2027)
    Figure 34. Global Antibody Revenue Market Share by Application (2016-2027)
    Figure 35. North America Antibody Sales Market Share by Type (2016-2027)
    Figure 36. North America Antibody Revenue Market Share by Type (2016-2027)
    Figure 37. North America Antibody Sales Market Share by Application (2016-2027)
    Figure 38. North America Antibody Revenue Market Share by Application (2016-2027)
    Figure 39. North America Antibody Sales Share by Country (2016-2027)
    Figure 40. North America Antibody Revenue Share by Country (2016-2027)
    Figure 41. U.S. Antibody Revenue (2016-2027) & (US$ Million)
    Figure 42. Canada Antibody Revenue (2016-2027) & (US$ Million)
    Figure 43. Europe Antibody Sales Market Share by Type (2016-2027)
    Figure 44. Europe Antibody Revenue Market Share by Type (2016-2027)
    Figure 45. Europe Antibody Sales Market Share by Application (2016-2027)
    Figure 46. Europe Antibody Revenue Market Share by Application (2016-2027)
    Figure 47. Europe Antibody Sales Share by Country (2016-2027)
    Figure 48. Europe Antibody Revenue Share by Country (2016-2027)
    Figure 49. Germany Antibody Revenue (2016-2027) & (US$ Million)
    Figure 50. France Antibody Revenue (2016-2027) & (US$ Million)
    Figure 51. U.K. Antibody Revenue (2016-2027) & (US$ Million)
    Figure 52. Italy Antibody Revenue (2016-2027) & (US$ Million)
    Figure 53. Russia Antibody Revenue (2016-2027) & (US$ Million)
    Figure 54. Asia Pacific Antibody Sales Market Share by Type (2016-2027)
    Figure 55. Asia Pacific Antibody Revenue Market Share by Type (2016-2027)
    Figure 56. Asia Pacific Antibody Sales Market Share by Application (2016-2027)
    Figure 57. Asia Pacific Antibody Revenue Market Share by Application (2016-2027)
    Figure 58. Asia Pacific Antibody Sales Share by Region (2016-2027)
    Figure 59. Asia Pacific Antibody Revenue Share by Region (2016-2027)
    Figure 60. China Antibody Revenue (2016-2027) & (US$ Million)
    Figure 61. Japan Antibody Revenue (2016-2027) & (US$ Million)
    Figure 62. South Korea Antibody Revenue (2016-2027) & (US$ Million)
    Figure 63. India Antibody Revenue (2016-2027) & (US$ Million)
    Figure 64. Australia Antibody Revenue (2016-2027) & (US$ Million)
    Figure 65. Taiwan Antibody Revenue (2016-2027) & (US$ Million)
    Figure 66. Indonesia Antibody Revenue (2016-2027) & (US$ Million)
    Figure 67. Thailand Antibody Revenue (2016-2027) & (US$ Million)
    Figure 68. Malaysia Antibody Revenue (2016-2027) & (US$ Million)
    Figure 69. Philippines Antibody Revenue (2016-2027) & (US$ Million)
    Figure 70. Latin America Antibody Sales Market Share by Type (2016-2027)
    Figure 71. Latin America Antibody Revenue Market Share by Type (2016-2027)
    Figure 72. Latin America Antibody Sales Market Share by Application (2016-2027)
    Figure 73. Latin America Antibody Revenue Market Share by Application (2016-2027)
    Figure 74. Latin America Antibody Sales Share by Country (2016-2027)
    Figure 75. Latin America Antibody Revenue Share by Country (2016-2027)
    Figure 76. Mexico Antibody Revenue (2016-2027) & (US$ Million)
    Figure 77. Brazil Antibody Revenue (2016-2027) & (US$ Million)
    Figure 78. Argentina Antibody Revenue (2016-2027) & (US$ Million)
    Figure 79. Middle East and Africa Antibody Sales Market Share by Type (2016-2027)
    Figure 80. Middle East and Africa Antibody Revenue Market Share by Type (2016-2027)
    Figure 81. Middle East and Africa Antibody Sales Market Share by Application (2016-2027)
    Figure 82. Middle East and Africa Antibody Revenue Market Share by Application (2016-2027)
    Figure 83. Middle East and Africa Antibody Sales Share by Country (2016-2027)
    Figure 84. Middle East and Africa Antibody Revenue Share by Country (2016-2027)
    Figure 85. Turkey Antibody Revenue (2016-2027) & (US$ Million)
    Figure 86. Saudi Arabia Antibody Revenue (2016-2027) & (US$ Million)
    Figure 87. U.A.E Antibody Revenue (2016-2027) & (US$ Million)
    Figure 88. Antibody Value Chain
    Figure 89. Antibody Production Process
    Figure 90. Channels of Distribution
    Figure 91. Distributors Profiles
    Figure 92. Bottom-up and Top-down Approaches for This Report
    Figure 93. Data Triangulation
    Figure 94. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
SecuX Technology Inc

RELATED REPORTS

Global Cytotoxicity Assay Market Size Status and Forecast 2021 2027
Global Cytotoxicity Assay Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-39V907
Sun Jul 18 00:00:00 UTC 2021

Add to Cart

Global Aquaculture Vaccine Market Size Status and Forecast 2021 2027
Global Aquaculture Vaccine Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-3I3192
Sun Jul 18 00:00:00 UTC 2021

Add to Cart

Global Intranasal Corticosteroids Market Size Status and Forecast 2021 2027
Global Intranasal Corticosteroids Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-25X2634
Sun Jul 18 00:00:00 UTC 2021

Add to Cart

Global Tumor Tracking System Market Size Status and Forecast 2021 2027
Global Tumor Tracking System Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-21F2812
Sun Jul 18 00:00:00 UTC 2021

Add to Cart